Monthly Archives: December 2018

12 December 2018

Istesso – Parkwalk investment

By |December 12th, 2018|

Parkwalk are delighted to welcome Istesso to its portfolio following an investment from the Parkwalk Opportunities EIS Fund.

Istesso is a drug development company working in the field of immunometabolism. It’s pre-clinical and clinical assets work by reprogramming cellular metabolism and have applications in autoimmune conditions. Istesso’s lead drug, MBS2320, is in a Phase 2a […]

MedaPhor – Parkwalk investment

By |December 11th, 2018|

We are delighted to announce that the Parkwalk Opportunities Fund has  participated in the recent financing round of Medaphor Group plc, the Cardiff University Spin-out and global provider of advanced ultrasound training simulators and ultrasound clinical support for medical professionals.

GOV.UK: Oxford Photovoltaics: a shining light in solar cell innovation

By |December 7th, 2018|

Oxford Photovoltaics: a shining light in solar cell innovation

Early support from Innovate UK kick-started Oxford University spin-out which has set a world record for converting sunlight into power.

Dr Chris Case and Professor Henry Snaith of Oxford Photovoltaics

An Oxfordshire company backed by early financial support from Innovate UK is developing next-generation solar cell technology for […]

Brainomix partners with Oxford University in UK Government funded £17.5 million AI Programme

By |December 7th, 2018|

Brainomix, an Oxford-based world leader in medical imaging software, is teaming up with the University of Oxford to become one of its technology providers for a £17.5m UK government funded project. Brainomix will demonstrate the significant health economic benefits of its AI-based proprietary imaging software solution, e-Stroke Suite, which is already used in routine clinical practice at […]

Ceres Power and Weichai finalise strategic collaboration and JV Agreement

By |December 4th, 2018|

Ceres Power (AIM: CWR, “Ceres”), a world-leading, low cost Solid Oxide Fuel Cell company, and Weichai Power (“Weichai”), one of the leading automobile and equipment manufacturing companies in China, are pleased to announce the finalisation of their long-term strategic collaboration first announced in May 2018. This includes a Joint Venture Agreement with the commitment […]

Parkwalk wins ‘Best Generalist EIS Fund’ in the Investment Week 2018/19 Tax Efficiency Awards

By |December 3rd, 2018|

Parkwalk are delighted to have won ‘Best General EIS Fund’ at Investment Week’s Tax Efficiency Awards 2018 last week, beating last year’s runner’s up prize and matching our win in 2016.

Parkwalk were also highly commended in the ‘Best Exit’ category.

It is always a good validation of our investment strategy to be recognised by industry peers […]

Deal or no deal, should EIS investors be worried about Brexit?

By |December 3rd, 2018|

Given the UK’s Venture Capital Schemes (SEIS, EIS, VCT and SITR) fall under the EU State Aid rules there is the possibility that a ‘hard’ Brexit would allow the Government to loosen restrictions regarding these schemes, but it seems unlikely given the Government’s agenda.

However, under any compromise deal the UK will probably have to […]